Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Three-times Weekly Dosing of GSK1278863 in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease Who Are Switched From a Stable Dose of an Erythropoiesis-stimulating Agent
Clinical trial NCT02689206 · COMPLETED
Trial details
- NCT number
- NCT02689206
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-17
- Primary completion
- 2017-01-25
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.